Matches in Wikidata for { <http://www.wikidata.org/entity/Q73288053> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q73288053 description "article scientifique publié en 2003" @default.
- Q73288053 description "artículu científicu espublizáu n'abril de 2003" @default.
- Q73288053 description "im April 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73288053 description "scientific article published on 01 April 2003" @default.
- Q73288053 description "wetenschappelijk artikel" @default.
- Q73288053 description "наукова стаття, опублікована у квітні 2003" @default.
- Q73288053 name "Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up" @default.
- Q73288053 name "Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up" @default.
- Q73288053 type Item @default.
- Q73288053 label "Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up" @default.
- Q73288053 label "Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up" @default.
- Q73288053 prefLabel "Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up" @default.
- Q73288053 prefLabel "Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up" @default.
- Q73288053 P1433 Q73288053-4F52E305-4636-413D-A6C0-00F8C3924A34 @default.
- Q73288053 P1476 Q73288053-DD961BEF-3B02-4C66-9ADC-5F678E2FC298 @default.
- Q73288053 P2093 Q73288053-044C479C-B42E-42A3-888C-3C50245D4370 @default.
- Q73288053 P2093 Q73288053-265AA479-5DF6-48C2-9232-BFF6E3DE4EC6 @default.
- Q73288053 P2093 Q73288053-5234FC12-8D02-4DFA-979E-0935834D9B7F @default.
- Q73288053 P2093 Q73288053-6ECEFBD5-33F8-4F66-8F95-13756E48CC5B @default.
- Q73288053 P2093 Q73288053-9E25B41D-82B5-4FB4-823C-00256CEA27D2 @default.
- Q73288053 P2093 Q73288053-C6D6F143-6E6E-4CAF-82C7-97C972CDBFE1 @default.
- Q73288053 P2860 Q73288053-03CC0A17-D033-4315-911D-06C4E9AEFB68 @default.
- Q73288053 P2860 Q73288053-08FE4496-8E03-4E58-9C1A-0023C056FAA1 @default.
- Q73288053 P2860 Q73288053-2CAB4A0F-015B-41C9-8C9A-1899F9569EA0 @default.
- Q73288053 P2860 Q73288053-538DE00B-69C9-4BBB-A3A8-31DAFBE8C82E @default.
- Q73288053 P2860 Q73288053-59AF19AA-CAD3-4E4F-9B3E-614C6C35DB6D @default.
- Q73288053 P2860 Q73288053-6A41C356-657F-4874-B014-E7273C117A60 @default.
- Q73288053 P2860 Q73288053-6EF66EEB-D22F-439E-ABA8-F584532FE491 @default.
- Q73288053 P2860 Q73288053-8468E437-E314-4059-924E-12DD17347A52 @default.
- Q73288053 P2860 Q73288053-CB0DA9A4-D1EF-4048-9ED5-A95BF7436546 @default.
- Q73288053 P2860 Q73288053-EE04A24E-53A8-4296-81B6-C870440C6827 @default.
- Q73288053 P304 Q73288053-F751C72A-0714-4EB2-B6C5-2AFBC15FF983 @default.
- Q73288053 P31 Q73288053-14021AB4-6E37-48E0-82C6-7A50CFE5BBFB @default.
- Q73288053 P356 Q73288053-9BBBC992-978C-41F3-9508-6C30613B8924 @default.
- Q73288053 P433 Q73288053-BD2C79A8-AEFE-4AF3-A11F-4689A543D949 @default.
- Q73288053 P478 Q73288053-628FD8BD-7399-4F71-A553-5E97B90E966D @default.
- Q73288053 P577 Q73288053-261F9431-2915-4DF1-94F9-7B2B68286AC8 @default.
- Q73288053 P698 Q73288053-539135B0-246B-4BFC-83A9-9E2EA4596699 @default.
- Q73288053 P356 J.1468-1293.2003.00148.X @default.
- Q73288053 P698 12702130 @default.
- Q73288053 P1433 Q15756376 @default.
- Q73288053 P1476 "Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up" @default.
- Q73288053 P2093 "Bratt G" @default.
- Q73288053 P2093 "Fredriksson EL" @default.
- Q73288053 P2093 "Hejdeman B" @default.
- Q73288053 P2093 "Leandersson AC" @default.
- Q73288053 P2093 "Sandström E" @default.
- Q73288053 P2093 "Wahren B" @default.
- Q73288053 P2860 Q34068078 @default.
- Q73288053 P2860 Q43726131 @default.
- Q73288053 P2860 Q43807839 @default.
- Q73288053 P2860 Q44192276 @default.
- Q73288053 P2860 Q45751987 @default.
- Q73288053 P2860 Q48760384 @default.
- Q73288053 P2860 Q52021113 @default.
- Q73288053 P2860 Q64133353 @default.
- Q73288053 P2860 Q73470103 @default.
- Q73288053 P2860 Q77810540 @default.
- Q73288053 P304 "101-110" @default.
- Q73288053 P31 Q13442814 @default.
- Q73288053 P356 "10.1046/J.1468-1293.2003.00148.X" @default.
- Q73288053 P433 "2" @default.
- Q73288053 P478 "4" @default.
- Q73288053 P577 "2003-04-01T00:00:00Z" @default.
- Q73288053 P698 "12702130" @default.